Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Nath Bio-Genes (India) Ltd. ( (IN:NATHBIOGEN) ) has issued an announcement.
Nath Bio-Genes (India) Ltd. has released an investor presentation covering its unaudited financial results for the quarter and nine months ended 31 December 2025, and has submitted this information to both BSE and the National Stock Exchange of India for investors’ review. The disclosure underscores the company’s ongoing engagement with capital markets and its commitment to financial transparency, providing stakeholders with updated performance data that may inform their assessment of the company’s operational trajectory and market positioning in the agribiotech and seeds sector.
More about Nath Bio-Genes (India) Ltd.
Nath Bio-Genes (India) Ltd. operates in the agribiotech and seeds industry, developing and marketing hybrid and high-yielding seed varieties for key crops in the Indian agriculture sector and related markets. The company focuses on supplying improved seed technologies to farmers, positioning itself within the organized seed and agri-inputs space on Indian stock exchanges BSE and NSE.
Average Trading Volume: 1,760
Technical Sentiment Signal: Sell
Current Market Cap: 2.76B INR
Find detailed analytics on NATHBIOGEN stock on TipRanks’ Stock Analysis page.